A second Trump administration could mean higher prices, less nutrition, and an increased risk of pathogens in the food supply ...
RFK Jr., a lawyer-politician, could replace lawyer-politician Xavier Becerra as Secretary of Health and Human Services. Or ...
1don MSNOpinion
Fortunately, the FDA has approved antipsychotic treatments that help manage these destructive symptoms, and more are in ...
Online health platforms continue to advertise access to copycat versions of blockbuster weight-loss drugs Wegovy and Zepbound ...
The Food and Drug Administration could now revoke over-the-counter designations for phenylephrine, an active ingredient in Benadryl and Sudafed. Pfizer’s COVID-19 pill: Here’s the latest on ...
verywellhealth on MSN5d
GLP-1 Drug Shortage Is Over. Why Might These Drugs Soon Be Costlier and Harder to Access?The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...
From family planning to hospital bills, the new Trump administration has the potential to affect a wide range of policies in ...
The Washington Post on MSN12d
RFK Jr. set for major food, health role in potential Trump administrationThe longtime anti-vaccine activist may be tapped as a White House czar, overseeing agencies responsible for vaccine approvals ...
Three states have picked up a lawsuit previously dismissed by the U.S. Supreme Court earlier this year against the Food and Drug Administration (FDA) over its removal of safety restrictions on ...
today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL), dated October 22, 2024, for the ketamine Abbreviated New Drug Application, which was ...
to the U.S. Food and Drug Administration (FDA) for vutrisiran, an investigational RNAi therapeutic in development for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM). Vutrisiran is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback